Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonia Serrano

Showing results (101-110 of 173) with videos related to

Pageof 18
Sort By:
Brain Structure & Function|July 8, 2021
Sudden cessation of fluoxetine before alcohol drinking reinstatement alters microglial morphology and TLR4/inflammatory neuroadaptation in the rat brainJesús Aranda, María Del Mar Fernández-Arjona, Francisco Alén, et al.
Neuropharmacology|July 7, 2026
Alcohol-fluoxetine co-treatment drives gut dysbiosis and intestinal barrier disruption with consequences for neuroimmune signaling in male ratsSonia Rohra-Benítez, Laura Sánchez-Marín, Paula Ruiz-Martín, et al.
Scientific Reports|August 3, 2021
Evaluation of neurotrophic factors and education level as predictors of cognitive decline in alcohol use disorderNerea Requena-Ocaña, Pedro Araos, María Flores, et al.
Disease Models & Mechanisms|June 28, 2012
Elaidyl-sulfamide, an oleoylethanolamide-modelled PPARα agonist, reduces body weight gain and plasma cholesterol in ratsJuan Manuel Decara, Miguel Romero-Cuevas, Patricia Rivera, et al.
Bioorganic & Medicinal Chemistry|February 26, 2013
Novel antiobesity agents: synthesis and pharmacological evaluation of analogues of Rimonabant and of LH21Mario Alvarado, Juan Decara, María Jesús Luque, et al.
International Journal of Molecular Sciences|June 10, 2023
Antipsychotic Medication Influences the Discriminative Value of Acylethanolamides as Biomarkers of Substance Use DisorderJesús Herrera-Imbroda, María Flores-López, Nerea Requena-Ocaña, et al.
Plos One|June 7, 2013
Pharmacological administration of the isoflavone daidzein enhances cell proliferation and reduces high fat diet-induced apoptosis and gliosis in the rat hippocampusPatricia Rivera, Margarita Pérez-Martín, Francisco J Pavón, et al.
Scientific Reports|January 25, 2020
Variation in chemokines plasma concentrations in primary care depressed patients associated with Internet-based cognitive-behavioral therapyPablo Romero-Sanchiz, Raquel Nogueira-Arjona, Pedro Araos, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 27, 2016
Cocaine-induced behavioral sensitization decreases the expression of endocannabinoid signaling-related proteins in the mouse hippocampusEduardo Blanco, Pablo Galeano, Ana Palomino, et al.
Biochemical Pharmacology|August 12, 2018
Pharmacological blockade of fatty acid amide hydrolase (FAAH) by URB597 improves memory and changes the phenotype of hippocampal microglia despite ethanol exposurePatricia Rivera, María Del Mar Fernández-Arjona, Daniel Silva-Peña, et al.
Pageof 18

Showing results (101-110 of 173) with videos related to

Sort By:
Pageof 18
Brain Structure & Function|July 8, 2021
Sudden cessation of fluoxetine before alcohol drinking reinstatement alters microglial morphology and TLR4/inflammatory neuroadaptation in the rat brainJesús Aranda, María Del Mar Fernández-Arjona, Francisco Alén, et al.
Neuropharmacology|July 7, 2026
Alcohol-fluoxetine co-treatment drives gut dysbiosis and intestinal barrier disruption with consequences for neuroimmune signaling in male ratsSonia Rohra-Benítez, Laura Sánchez-Marín, Paula Ruiz-Martín, et al.
Scientific Reports|August 3, 2021
Evaluation of neurotrophic factors and education level as predictors of cognitive decline in alcohol use disorderNerea Requena-Ocaña, Pedro Araos, María Flores, et al.
Disease Models & Mechanisms|June 28, 2012
Elaidyl-sulfamide, an oleoylethanolamide-modelled PPARα agonist, reduces body weight gain and plasma cholesterol in ratsJuan Manuel Decara, Miguel Romero-Cuevas, Patricia Rivera, et al.
Bioorganic & Medicinal Chemistry|February 26, 2013
Novel antiobesity agents: synthesis and pharmacological evaluation of analogues of Rimonabant and of LH21Mario Alvarado, Juan Decara, María Jesús Luque, et al.
International Journal of Molecular Sciences|June 10, 2023
Antipsychotic Medication Influences the Discriminative Value of Acylethanolamides as Biomarkers of Substance Use DisorderJesús Herrera-Imbroda, María Flores-López, Nerea Requena-Ocaña, et al.
Plos One|June 7, 2013
Pharmacological administration of the isoflavone daidzein enhances cell proliferation and reduces high fat diet-induced apoptosis and gliosis in the rat hippocampusPatricia Rivera, Margarita Pérez-Martín, Francisco J Pavón, et al.
Scientific Reports|January 25, 2020
Variation in chemokines plasma concentrations in primary care depressed patients associated with Internet-based cognitive-behavioral therapyPablo Romero-Sanchiz, Raquel Nogueira-Arjona, Pedro Araos, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 27, 2016
Cocaine-induced behavioral sensitization decreases the expression of endocannabinoid signaling-related proteins in the mouse hippocampusEduardo Blanco, Pablo Galeano, Ana Palomino, et al.
Biochemical Pharmacology|August 12, 2018
Pharmacological blockade of fatty acid amide hydrolase (FAAH) by URB597 improves memory and changes the phenotype of hippocampal microglia despite ethanol exposurePatricia Rivera, María Del Mar Fernández-Arjona, Daniel Silva-Peña, et al.
Pageof 18